OpenAlex
PricingAboutJobs
Log inGet started
Work

Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.

PubMed

Year: 2002
Type: article
Source: PubMed
Authors: John M L Ebos, Jennifer Tran, Zubin Master, Daniel Dumont, Junia V Melo, Elisabeth Buchdunger, Robert S Kerbel
Institutions: Sunnybrook Health Science Centre, University of Toronto, Hammersmith Hospital, Novartis (Switzerland), Novartis (United States)
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib mesylate, imatinib, BCR-ABL, chronic myeloid leukemia, vascular endothelial growth factor, angiogenesis, K562 cells, Akt signaling, interleukin-3, GM-CSF, imatinib resistance, endothelial cell survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2186650217
FWCI: 5.351
Cites: 39
Cited by: 85
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms